- Vertex was sole bidder in high-premium Crinetics acquisition<p>Analysts expect new details on the lead-up to the deal “are likely to reignite” investor scrutiny that Vertex overpaid in what’s poised to be its largest-ever transaction.</p>BioPharma Dive · 2d ago↗ source
- GSK lung cancer drug gets speedy approval following $10.6B deal<figure><div><img src="https://imgproxy.divecdn.com/c0irKiK7j9tqBFXMPegw7r6KQcBI9zHl6OgHMT-b53A/g:nowe:0:353/c:4765:2692/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9OZXdfR1NLSC5qc…BioPharma Dive · 2d ago↗ source
- FDA swiftly puts Makary era in the rearview mirrorAs the White House mulls a pick to lead the FDA, the Trump administration has been washing away the mark of former Commissioner Marty Makary, in a refresh that includes everything from reconsidered…